• News / Press
  • Contact
Arcutis Biotherapeutics Logo
Bioscience, applied to the skin
  • Who We Are
    • Vision
    • Leadership
    • Board of Directors
    • Scientific Advisors
    • Strategic Collaborations
  • Our Focus
    • Plaque Psoriasis
    • Atopic Dermatitis
    • Eczema
    • Vitiligo
    • Alopecia Areata
  • Pipeline
    • ARQ-151
    • ARQ-252
  • Clinical Trials
  • Investors
Arcutis Biotherapeutics Logo
bubble image

News / Press

Arcutis Inc. to Present at RBC Conference

Posted on May 9, 2019 by ArqAdmin - Press Releases

RBC-Conf-Annc-FINAL
Download

Recent Posts

  • Arcutis Announces Enrollment of Last Patient in Phase 2a Clinical Trial of ARQ-151 Cream as a Potential Topical Treatment for Atopic Dermatitis
  • Arcutis, Inc.’s Development Program for Eczema
  • Arcutis, Inc. Announces Positive Top Line Results for Phase 2b Clinical Trial Evaluating ARQ-151 as a Potential Topical Treatment for Plaque Psoriasis
  • Scott Burrows Joins Arcutis as VP, Finance
  • ARQ-151 Atopic Dermatitis P2a Trial Initiated

Archives

  • October 2019
  • September 2019
  • July 2019
  • June 2019
  • May 2019
  • April 2019

Categories

  • Press Releases
Arcutis Biotherapeutics Logo
805.418.5006
information@arcutis.com
  • linkedin
  • Who We Are
  • Our Focus
  • Pipeline
  • Clinical Trials
  • Investors
  • Contact
  • News / Press
  • Legal Disclaimer

© 2019 Arcutis Biotherapeutics

Designed By Watermark